We carefully select commercial-stage companies offering better, faster, and more cost-effective solutions aligned with healthcare’s Triple Aim. We participate as a trusted partner investing significant human capital to leverage our decades of experience and empower our companies with capital to build and scale their sales and marketing infrastructure.
We prioritize investments in companies with FDA approval and clear reimbursement pathways supported by compelling clinical evidence. This approach not only ensures sustainable growth but also underscores our commitment to making impactful contributions to healthcare outcomes, advancing innovation and improving patient care.
